Entia Biosciences Inc (ERGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16 | 23 | 37 | 45 | 13 |
| Receivables | 31 | 36 | 15 | 98 | 86 |
| Inventories | 113 | 128 | 139 | 128 | 108 |
| Other current assets | 1 | 1 | 0 | 0 | 0 |
| TOTAL | $184 | $216 | $226 | $285 | $225 |
| Non-Current Assets | |||||
| PPE Net | 53 | 56 | 62 | 72 | 62 |
| Intangibles | 343 | 343 | 344 | 346 | 335 |
| TOTAL | $396 | $400 | $406 | $418 | $397 |
| Total Assets | $580 | $616 | $631 | $704 | $622 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,303 | 1,350 | 1,158 | 912 | 801 |
| TOTAL | $1,924 | $1,831 | $1,581 | $1,381 | $1,313 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 16 | 0 | 0 | 0 |
| TOTAL | $N/A | $16 | $N/A | $2 | $2 |
| Total Liabilities | $1,924 | $1,846 | $1,581 | $1,383 | $1,315 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,360 | 8,437 | 8,298 | 7,945 | 7,728 |
| Common Shares | 9 | 8 | 8 | 8 | 8 |
| Retained earnings | -9,567 | -9,056 | -8,520 | -7,369 | -6,819 |
| Other shareholders' equity | -188 | -268 | -232 | -282 | -332 |
| TOTAL | $-1,345 | $-1,231 | $-950 | $-680 | $-693 |
| Total Liabilities And Equity | $580 | $616 | $631 | $704 | $622 |